ATS Conference 2024 – Apply to be Featured
American Thoracic Society
American Thoracic Society
KFF’s latest Health Tracking Poll examines the public’s views and use of an an increasingly popular class of prescription drugs used for weight loss and…
Rationale: A phase II trial reported clinical benefit over 28 weeks in patients with idiopathic pulmonary fibrosis (IPF) who received zinpentraxin alfa. Objectives: To investigate the…
Rationale: Diffuse alveolar hemorrhage (DAH) is a life-threatening manifestation of antineutrophil cytoplasmic antibody–associated vasculitis (AAV). The PEXIVAS (Plasma Exchange and Glucocorticoids…
Background Ivacaftor (IVA) improves lung function and other extrapulmonary outcomes in people with cystic fibrosis (CF). However, the effect of initiating IVA at earlier versus…
NEJM Group offers live web events covering the important topics impacting health care. See our upcoming schedule.
Proof that nintedanib and pirfenidone slow progression of idiopathic pulmonary fibrosis (IPF) has sparked further clinical trials that are being pursued in the hope of…
The ERS HERMES self-assessment course in adult respiratory medicine provides a unique opportunity to test your applied knowledge in adult respiratory medicine against 30 high-quality,…
KFF’s latest Health Tracking Poll examines the public’s views and use of an an increasingly popular class of prescription drugs used for weight loss and…
Society of Critical Care Medicine updated guidance on corticosteroids in sepsis, ARDS, and community-acquired pneumonia.